Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Effects of nicotine and mecamylamine on choice accuracy in an operant visual signal detection task in female rats.

Rezvani AH, Bushnell PJ, Levin ED.

Psychopharmacology (Berl). 2002 Dec;164(4):369-75. Epub 2002 Sep 20.

PMID:
12457266
2.

Acute and chronic nicotinic interactions with dopamine systems and working memory performance.

Levin ED, Rose JE.

Ann N Y Acad Sci. 1995 May 10;757:245-52. Review.

PMID:
7611680
3.

Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization.

Levin ED, McClernon FJ, Rezvani AH.

Psychopharmacology (Berl). 2006 Mar;184(3-4):523-39. Epub 2005 Oct 12. Review.

PMID:
16220335
4.

Nicotinic acetylcholine involvement in cognitive function in animals.

Levin ED, Simon BB.

Psychopharmacology (Berl). 1998 Aug;138(3-4):217-30. Review.

PMID:
9725745
5.

The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry.

Robbins TW.

Psychopharmacology (Berl). 2002 Oct;163(3-4):362-80. Epub 2002 Aug 9. Review.

PMID:
12373437
6.

Mecamylamine - a nicotinic acetylcholine receptor antagonist with potential for the treatment of neuropsychiatric disorders.

Bacher I, Wu B, Shytle DR, George TP.

Expert Opin Pharmacother. 2009 Nov;10(16):2709-21. doi: 10.1517/14656560903329102. Review.

PMID:
19874251
7.

Attention-modulating effects of cognitive enhancers.

Levin ED, Bushnell PJ, Rezvani AH.

Pharmacol Biochem Behav. 2011 Aug;99(2):146-54. doi: 10.1016/j.pbb.2011.02.008. Epub 2011 Feb 18. Review.

8.
9.

Baseline-dependency of nicotine effects: a review.

Perkins KA.

Behav Pharmacol. 1999 Nov;10(6-7):597-615. Review.

PMID:
10780501
10.

Identifying experimental methods to determine the effect of pain on attention: a review of pain, caffeine, alcohol and nicotine studies.

Moore DJ, Keogh E, Eccleston C.

Hum Psychopharmacol. 2009 Dec;24(8):601-18. doi: 10.1002/hup.1072. Review.

PMID:
19946936
11.

Mecamylamine (Inversine): an old antihypertensive with new research directions.

Shytle RD, Penny E, Silver AA, Goldman J, Sanberg PR.

J Hum Hypertens. 2002 Jul;16(7):453-7. Review.

12.

Functional brain imaging of nicotinic effects on higher cognitive processes.

Newhouse PA, Potter AS, Dumas JA, Thiel CM.

Biochem Pharmacol. 2011 Oct 15;82(8):943-51. doi: 10.1016/j.bcp.2011.06.008. Epub 2011 Jun 13. Review.

13.

Potential therapeutic uses of mecamylamine and its stereoisomers.

Nickell JR, Grinevich VP, Siripurapu KB, Smith AM, Dwoskin LP.

Pharmacol Biochem Behav. 2013 Jul;108:28-43. doi: 10.1016/j.pbb.2013.04.005. Epub 2013 Apr 18. Review.

14.

Mecamylamine: new therapeutic uses and toxicity/risk profile.

Young JM, Shytle RD, Sanberg PR, George TP.

Clin Ther. 2001 Apr;23(4):532-65. Review.

PMID:
11354389
15.

Attention and stimulus processing in the rat.

Muir JL.

Brain Res Cogn Brain Res. 1996 Jun;3(3-4):215-25. Review.

PMID:
8806024
16.

What is the nature of mecamylamine's antagonism of the central effects of nicotine?

Martin BR, Onaivi ES, Martin TJ.

Biochem Pharmacol. 1989 Oct 15;38(20):3391-7. Review. No abstract available.

PMID:
2684166
17.

Assessment of attentional function and impulsivity using 5-choice serial reaction time task/3-choice serial reaction time task.

Ohmura Y, Tsutsui-Kimura I, Yoshioka M.

Nihon Yakurigaku Zasshi. 2009 Sep;134(3):137-41. Review. No abstract available.

PMID:
19749485
18.

Fuzzy signal detection theory: basic postulates and formulas for analyzing human and machine performance.

Parasuraman R, Masalonis AJ, Hancock PA.

Hum Factors. 2000 Winter;42(4):636-59. Review.

PMID:
11324856
19.

Cumulative progress in formal theories of attention.

Logan GD.

Annu Rev Psychol. 2004;55:207-34. Review.

PMID:
14744215
Items per page

Supplemental Content

Write to the Help Desk